drugset
drugset / Trial / NCT04252339

RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors

NCT04252339 ↗

Phase 1 Completed 56 enrolled Hoffmann-La Roche
NaSequentialOpen-labelTreatment

Summary

This study is a multi-center, open-label, dose escalation and expansion study of RLY-1971 in subjects with advanced or metastatic solid tumors.

Timeline

Start
2020-02-04
Primary completion
2022-11-22
Completion
2022-11-22

Drugs

EvaluationDrugModalityDoseRoute
Subject MIGOPROTAFIB Small molecule — Oral

Indications

cancer